CD4 and viral infectious disease: The concentrations of AMD3100 necessary to achieve 50% inhibition of HIV-1-LAI passage across the BeWo cells monolayer were 1.6 and 3 times, for CD4 negative and positive BeWo cells, respectively, higher than the IC50 required to block cell-free virus infection of PBMC.